Cited by 668T-cell and B-cell ImmunologySystemic Lupus Erythematosus ResearchCytokine Signaling Pathways and Interactions

Regulation of B Cell Differentiation and Plasma Cell Generation by IL-21, a Novel Inducer of Blimp-1 and Bcl-6

Open access
Ozaki, Katsutoshi, Spolski, Rosanne, Ettinger, Rachel, Kim, Hyoung-Pyo, Wang, Gang, Qi, Chen-Feng, Hwu, Patrick, Shaffer, Daniel J +5 more·2004·The Journal of Immunology

Abstract

IL-21 is a type I cytokine whose receptor is expressed on T, B, and NK cells. Within the B cell lineage, IL-21 regulates IgG1 production and cooperates with IL-4 for the production of multiple Ab classes in vivo. Using IL-21-transgenic mice and hydrodynamics-based gene delivery of IL-21 plasmid DNA into wild-type mice as well as in vitro studies, we demonstrate that although IL-21 induces death of resting B cells, it promotes differentiation of B cells into postswitch and plasma cells. Thus, IL-21 differentially influences B cell fate depending on the signaling context, explaining how IL-21 can be proapoptotic for B cells in vitro yet critical for Ag-specific Ig production in vivo. Moreover, we demonstrate that IL-21 unexpectedly induces expression of both Blimp-1 and Bcl-6, indicating mechanisms as to how IL-21 can serve as a complex regulator of B cell maturation and terminal differentiation. Finally, BXSB-Yaa mice, which develop a systemic lupus erythematosus-like disease, have greatly elevated IL-21, suggesting a role for IL-21 in the development of autoimmune disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.173.9.5361

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hypergammaglobulinemia and autoantibody production could be an epiphenomenon of immune activation in autoimmune hepatitis.

    “This supports the hypothesis that both hypergammaglobulinemia and autoantibody production could only be an epiphenomenon of the immune activation.”

    From The liver as a central "hub" of the immune system: pathophysiological implications (2025) · cites this paper as [383]

    The discussion section (page unavailable) suggests that elevated IL-21 may account for hypergammaglobulinemia in a mouse model of lupus, linking elevated immunoglobulins to an immune process. It does not address autoimmune hepatitis or establish that hypergammaglobulinemia and autoantibody production are merely epiphenomena of immune activation. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Ozaki, K., K. Kikly, D. Michalovich, P. R. Young, and W. J. Leonard. 2000. Cloning of a type I cytokine receptor most related to the IL-2 receptor ␤ chain. Proc. Natl. Acad. Sci. USA 97:11439.

Cited by

Sorted by citations

Authors
Ozaki, K., Spolski, R., Ettinger, R., Kim, H.-P., Wang, G., Qi, C.-F., Hwu, P., Shaffer, D. J., Akilesh, S., Roopenian, D. C., Morse, H. C., Lipsky, P. E., & Leonard, W. J.
Affiliations
  • National Heart, Lung, and Blood Institute (US)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (US)
  • National Cancer Institute (MY)
  • National Institutes of Health (US)
  • Jackson Laboratory (US)
Corresponding author
  • Ozaki, Katsutoshi
  • Spolski, Rosanne
Venue
The Journal of Immunology
Published
2004-11-01
Volume
173
Issue
9
Pages
5361-5371
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2102364213
Cited by
668
References
1
Citations by year
2026: 11 · 2025: 16 · 2024: 18 · 2023: 18 · 2022: 14 · 2021: 24 · 2020: 18 · 2019: 28 · 2018: 24 · 2017: 25 · 2016: 46 · 2015: 42 · 2014: 47 · 2013: 41 · 2012: 41
FWCI
10.12
Type
journal article
Language
en
Open access
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (DK-56597, R01DK056597)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
Keywords
IL-21, B cell differentiation, Blimp-1, BCL6, B cell fate, antibody class switching, B cell apoptosis, IL-4, systemic lupus erythematosus, autoimmune disease, type I cytokines
MeSH terms
Positive Regulatory Domain I-Binding Factor 1, Interleukin-21, Animals, Cell Division, Cell Separation, Cells, Cultured, DNA-Binding Proteins, Humans, Interleukins, Lupus Erythematosus, Systemic, Membrane Glycoproteins, Mice, Inbred C57BL, Mice, Mutant Strains, Mice, Transgenic, Plasma Cells, Proteoglycans, Proto-Oncogene Proteins, Repressor Proteins, Spleen, Transcription Factors, Up-Regulation, B-Lymphocyte Subsets, Apoptosis, Immunoglobulin Class Switching, Mice, Knockout, Lymphocyte Count, Mice, Proto-Oncogene Proteins c-bcl-6, PAX5 Transcription Factor, Syndecans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review